Forbes Breaking News
@ForbesBreakingNews·5.5M subscribers·180.5K videos
Kirsten Gillibrand Asks Advocate: How Should Congress Increase Oversight, Transparency Of Rx Drugs?
Posted
June 18, 2026
Views
358
Likes
3
Comments
22
Engagement
June 18, 2026
358
3
22
6.98%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
10:08Now PlayingDuring a Senate Aging Committee hearing earlier this month, Sen. Kirsten Gillibrand (D-NY) asked Founder & CEO of the Hypertrophic Cardiomyopathy Association Lisa Salberg about transparency for prescription drugs.
Stay Connected
Forbes Breaking News on X
Forbes Breaking News on TikTok
More From Forbes
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
